SogaYMiiSIidaOPropensity score analysis of clinical outcome after bypass
surgery vs. endovascular therapy for infrainguinal artery disease in
patients with critical limb ischemia. J Endovasc
Ther.
2014;21:243–253
2.
AdamDJBeardJDClevelandTBASIL
trial participants. Bypass versus angioplasty in
severe ischaemia of the leg (BASIL): multicentre, randomised controlled
trial. Lancet.
2005;366:1925–1934
3.
NorgrenLHiattWRDormandyJAInter-Society Consensus for the Management of Peripheral Arterial
Disease (TASC II). J Vasc Surg.
2007;45Suppl S:S5–67
4.
DormandyJARutherfordRB.Management of peripheral arterial disease (PAD). TASC Working
Group. TransAtlantic Inter-Society Consensus (TASC).
J Vasc Surg.
2000;31:S1–S296
5.
BoliaABrennanJBellPR.Recanalisation of femoro-popliteal occlusions: improving success
rate by subintimal recanalisation. Clin
Radiol.
1989;40:325
6.
O'SullivanCJHynesNMahendranBHaemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular
patients. Is HbA1c an independent risk factor and predictor of adverse
outcome?Eur J Vasc Endovasc Surg.
2006;32:188–197
7.
SultanSHynesN.Homocysteine as a risk factor in atherosclerotic cardiovascular
disease. In: StanleyJCVeithFJWakefieldTW
eds. Current Therapy in Vascular and Endovascular Surgery,
4th ed.Philadelphia, PA:
Saunders; 2011
8.
WatersPSFennesseyPJHynesNThe effects of normalizing hyperhomocysteinemia on clinical and
operative outcomes in patients with critical limb ischemia.
J Endovasc Ther.
2012;19:815–825
9.
HeneghanHMSultanS.Homocysteine, the cholesterol of the 21st century. Impact of
hyperhomocysteinemia on patency and amputation-free survival after
intervention for critical limb ischemia. J Endovasc
Ther.
2008;15:399–407
10.
SultanSTawfickWHynesN.Ten-year technical and clinical outcomes in TransAtlantic
Inter-Society Consensus II infrainguinal C/D lesions using duplex ultrasound
arterial mapping as the sole imaging modality for critical lower limb
ischemia in a high-volume specialist center. J Vasc
Surg.
2013;57:1038–1045
11.
LoweryAJHynesNSultanS.A prospective feasibility study of duplex ultrasound arterial
mapping, digital-subtraction angiography, and magnetic resonance angiography
in management of critical lower limb ischemia by endovascular
revascularization. Ann Vasc Surg.
2007;21:443–451
12.
HynesNSultanS.The influence of subintimal angioplasty on level of amputation
and limb salvage rates in lower limb critical ischaemia: a 15-year
experience. Eur J Vasc Endovasc Surg.
2005;30:291–299
13.
LairdJRKatzenBTScheinertDNitinol stent implantation vs. balloon angioplasty for lesions in
the superficial femoral and proximal popliteal arteries of patients with
claudication: three-year follow-up from the RESILIENT randomized
trial. J Endovasc Ther.
2012;19:1–9
14.
SultanSHynesN.Five-year Irish trial of CLI patients with TASC II type C/D
lesions undergoing subintimal angioplasty or bypass surgery based on plaque
echolucency. J Endovasc Ther.
2009;16:270–283
15.
SultanSTawfickWHynesN.Cool excimer laser-assisted angioplasty (CELA) and tibial balloon
angioplasty (TBA) in management of infragenicular arterial occlusion in
critical lower limb ischemia (CLI). Vasc
Endovascular Surg.
2013;47:179–191
16.
TawfickWAHamadaNSoyluESequential compression biomechanical device versus primary
amputation in patients with critical limb ischemia.
Vasc Endovascular Surg.
2013;47:532–539
17.
SultanSHamadaNSoyluEThe results of the sequential compression biomechanical device in
patients with critical limb ischemia and nonreconstructible peripheral
vascular disease. J Vasc Surg.
2011;54:440–446